Enhancer ID: | E_02_026 | |
Enhancer symbol: | -- | |
Species: | Mouse | |
Position : | chr5:147267701-147267751 |
|
Biosample name: | HIT,Hep G2,INS-1 | |
Experiment class : | Low throughput |
Enhancer type: | Enhancer | |
Disease: | Diabetes Mellitus | |
DO: | DOID:9351 | |
Mesh: | D003920 | |
Distance from TSS: | >2KB | |
Pubmed ID: | 21652712 |
Enhancer experiment: | Transfection,Luciferase Reporter Assay,EMSA,ChIP,qPCR | |
Enhancer experiment description: | Previous studies have identified several transcriptional factors for the Pdx-1 promoter that consists of two important regulatory regions as follows: the proximal and distal enhancer regions.To delineate the sites responsible for SREBP-lc suppression oí Pdx-1, we generated a series of 5'-deletion constructs and analyzed these reporters by transfection into HIT cells (Fig.2C). SREBP-lc-mediated inhibition was completely abolished In PDX-1 (-93)-Luc. |
Target gene : | Pdx1(IDX-1,IPF-1,Ipf1,Mody4,STF-1,pdx-1) | |
Strong evidence: | -- | |
Less strong evidence: | Luciferase Reporter Assay,EMSA | |
Target gene experiment description: | SREBP-lc-mediated inhibition was completely abolished In PDX-1 (-93)-Luc. In the distal enhancer region, EMSA analysis showed that potent binding of PDX-1 to the probe containing a PDX-1 -binding site in area I (-2517 to - 2492 bp) was dose-dependently inhibited by SREBP-lc (Fig. 6) |
TF name : | Pdx1(GSF,IDX-1,IPF1,IUF1,MODY4,PAGEN1,PDX-1,STF-1) | |
TF experiment: | EMSA | |
TF experiment description: | In the distal Enhancer region,EMSA analysis showed that potent binding of PDX-1 to the probe containing a PDX-1 -binding site in area I (-2517 to - 2492 ) was dose-dependently inhibited by SRE -lc. |
Enhancer function : | -- |
Enhancer function experiment: | -- |
Enhancer function experiment description: |
-- |
SNP ID: | -- | |
SNP position: | -- |
SNP experiment: | -- |
Home | Browse | Search | Download | Genome-Browser | Submit | Contact | Help
Copyright © HMU | 黑ICP备16009434号-1 | Li C Lab